Shattuck Labs, Inc. Increase (Decrease) in Other Operating Assets
Shattuck Labs, Inc. (STTK) reported Increase (Decrease) in Other Operating Assets of $26.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-11
- Shattuck Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$6.00K.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $32.00K.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $12.00K.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$59.00K.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$79.00K.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$90.00K.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for fiscal 2023 was -$165.00K, a 411.32% decline from fiscal 2022.
- Shattuck Labs, Inc. increase (decrease) in other operating assets for fiscal 2022 was $53.00K, a 65.63% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $26.00K 10-Q · filed 2026-08-11 | $38.00K derived: sum of 3 quarters · filed 2026-08-11 | -$21.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $32.00K 10-Q · filed 2026-05-07 | $44.00K derived: sum of 2 quarters · filed 2026-05-07 | -$15.00K derived: sum of 3 quarters · filed 2026-05-07 | -$31.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$47.00K derived: sum of 2 quarters · filed 2026-03-05 | -$63.00K derived: sum of 3 quarters · filed 2026-08-11 | -$79.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$75.00K derived: sum of 2 quarters · filed 2026-08-11 | -$91.00K 10-Q · filed 2025-11-06 | -$109.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$32.00K 10-Q · filed 2026-08-11 | -$50.00K derived: sum of 3 quarters · filed 2026-08-11 | -$82.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$16.00K 10-Q · filed 2026-05-07 | -$34.00K derived: sum of 2 quarters · filed 2026-05-07 | -$66.00K derived: sum of 3 quarters · filed 2026-05-07 | -$96.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$50.00K derived: sum of 2 quarters · filed 2026-03-05 | -$80.00K derived: sum of 3 quarters · filed 2026-03-05 | -$90.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$62.00K derived: sum of 2 quarters · filed 2025-11-06 | -$72.00K 10-Q · filed 2025-11-06 | -$108.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$40.00K 10-Q · filed 2025-08-14 | -$76.00K derived: sum of 3 quarters · filed 2025-08-14 | -$116.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$10.00K 10-Q · filed 2025-05-01 | -$46.00K derived: sum of 2 quarters · filed 2025-05-01 | -$86.00K derived: sum of 3 quarters · filed 2025-05-01 | -$145.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$76.00K derived: sum of 2 quarters · filed 2025-03-27 | -$135.00K derived: sum of 3 quarters · filed 2025-03-27 | -$165.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$99.00K derived: sum of 2 quarters · filed 2024-11-14 | -$129.00K 10-Q · filed 2024-11-14 | -$163.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$89.00K 10-Q · filed 2024-08-01 | -$123.00K derived: sum of 3 quarters · filed 2024-08-01 | -$23.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$30.00K 10-Q · filed 2024-05-02 | -$64.00K derived: sum of 2 quarters · filed 2024-05-02 | $36.00K derived: sum of 3 quarters · filed 2024-05-02 | $48.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $66.00K derived: sum of 2 quarters · filed 2024-02-29 | $78.00K derived: sum of 3 quarters · filed 2024-02-29 | $53.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $112.00K derived: sum of 2 quarters · filed 2023-11-09 | $87.00K 10-Q · filed 2023-11-09 | $194.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$13.00K 10-Q · filed 2023-08-10 | $94.00K derived: sum of 3 quarters · filed 2023-08-10 | $37.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$25.00K 10-Q · filed 2023-05-09 | $82.00K derived: sum of 2 quarters · filed 2023-05-09 | $25.00K derived: sum of 3 quarters · filed 2023-05-09 | -$6.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $50.00K derived: sum of 2 quarters · filed 2023-02-23 | $19.00K derived: sum of 3 quarters · filed 2023-02-23 | $32.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$88.00K derived: sum of 2 quarters · filed 2022-11-09 | -$75.00K 10-Q · filed 2022-11-09 | $218.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$18.00K 10-Q · filed 2022-08-11 | $275.00K derived: sum of 3 quarters · filed 2022-08-11 | $308.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-12 | $306.00K derived: sum of 2 quarters · filed 2022-05-12 | $339.00K derived: sum of 3 quarters · filed 2022-05-12 | $406.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $326.00K derived: sum of 2 quarters · filed 2022-03-15 | $393.00K derived: sum of 3 quarters · filed 2022-03-15 | $326.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $100.00K derived: sum of 2 quarters · filed 2021-11-09 | $33.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$67.00K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |